Posted on 15 April 2016
Dr Kenton Zavitz, Director of Clinical Affairs will be joining Inventiv Health in their webinar on Assessing Cognitive Safety of Drugs in Clinical Development.
Posted on 6 April 2016
Cambridge Cognition and Ctrl Group Limited are presenting the first prototype of a ground-breaking new software application to improve the understanding, diagnosis and treatment of mental health ahead of schedule on April 7 at the Neurotech Investing and Partnering Conference in Boston, MA
Posted on 31 March 2016
The 5th Biennial Schizophrenia International Research Society Conference will take place 2-6 April 2016 in Florence, Italy at the Firenze Fiera Congress Center.
Posted on 23 March 2016
BioMarin announced on 21st March 2016 that the Phase 3 PRISM-2 study of pegvaliase met the primary endpoint of change in blood Phe compared with placebo (p<0.0001) in preliminary results.